T2 Biosystems IncNASDAQ:TTOONASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE3.6300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.7200/ 6
- Ask / Lots3.8500/ 31
- Open / Previous Close0.0000 / 3.6300
- Day Range---
- 52 Week Range
- Volume73,788
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TTOO |
|---|---|---|
| 09:32 ET | 13683 | 3.3001 |
| 09:34 ET | 1150 | 3.445 |
| 09:36 ET | 1800 | 3.35 |
| 09:38 ET | 4702 | 3.33 |
| 09:39 ET | 2336 | 3.35 |
| 09:41 ET | 2887 | 3.4767 |
| 09:43 ET | 6778 | 3.45 |
| 09:45 ET | 1000 | 3.4041 |
| 09:48 ET | 1250 | 3.43 |
| 09:50 ET | 1441 | 3.4337 |
| 09:52 ET | 574 | 3.4899 |
| 09:54 ET | 100 | 3.4899 |
| 09:56 ET | 1222 | 3.4884 |
| 09:57 ET | 5228 | 3.5 |
| 09:59 ET | 394 | 3.5 |
| 10:03 ET | 431 | 3.48 |
| 10:06 ET | 1966 | 3.5255 |
| 10:08 ET | 4431 | 3.6157 |
| 10:19 ET | 162 | 3.56 |
| 10:21 ET | 995 | 3.6499 |
| 10:24 ET | 100 | 3.625 |
| 10:30 ET | 100 | 3.62 |
| 10:32 ET | 600 | 3.6001 |
| 10:35 ET | 1988 | 3.5634 |
| 10:37 ET | 200 | 3.6399 |
| 10:39 ET | 200 | 3.6 |
| 10:42 ET | 100 | 3.6 |
| 10:48 ET | 1500 | 3.56 |
| 10:51 ET | 100 | 3.57 |
| 10:53 ET | 200 | 3.6 |
| 10:57 ET | 1598 | 3.55 |
| 11:09 ET | 100 | 3.53 |
| 11:11 ET | 219 | 3.5014 |
| 11:15 ET | 2000 | 3.51 |
| 11:18 ET | 499 | 3.52 |
| 11:26 ET | 907 | 3.52 |
| 11:33 ET | 1500 | 3.53 |
| 11:36 ET | 600 | 3.5953 |
| 11:42 ET | 100 | 3.56 |
| 11:45 ET | 1461 | 3.5484 |
| 11:56 ET | 750 | 3.56 |
| 12:00 ET | 163 | 3.52 |
| 12:02 ET | 650 | 3.5384 |
| 12:05 ET | 905 | 3.56 |
| 12:16 ET | 100 | 3.5507 |
| 12:20 ET | 100 | 3.5401 |
| 12:21 ET | 686 | 3.54 |
| 12:23 ET | 300 | 3.56 |
| 12:30 ET | 1905 | 3.6 |
| 12:38 ET | 6235 | 3.65 |
| 12:39 ET | 1237 | 3.6786 |
| 12:41 ET | 2306 | 3.7 |
| 12:43 ET | 979 | 3.7 |
| 12:48 ET | 2100 | 3.71 |
| 12:50 ET | 100 | 3.69 |
| 12:54 ET | 100 | 3.709 |
| 12:59 ET | 180 | 3.706 |
| 01:01 ET | 3000 | 3.6838 |
| 01:08 ET | 979 | 3.6601 |
| 01:17 ET | 700 | 3.675 |
| 01:26 ET | 148 | 3.68 |
| 01:42 ET | 6622 | 3.6 |
| 01:48 ET | 395 | 3.6858 |
| 01:55 ET | 4950 | 3.6101 |
| 02:08 ET | 1132 | 3.67 |
| 02:09 ET | 4000 | 3.6465 |
| 02:22 ET | 400 | 3.665 |
| 02:24 ET | 1122 | 3.7 |
| 02:27 ET | 230 | 3.6587 |
| 02:31 ET | 100 | 3.68 |
| 02:36 ET | 300 | 3.6899 |
| 02:38 ET | 100 | 3.7 |
| 02:40 ET | 500 | 3.66 |
| 02:42 ET | 975 | 3.67 |
| 02:44 ET | 200 | 3.6601 |
| 02:45 ET | 100 | 3.68 |
| 02:47 ET | 2210 | 3.68 |
| 02:49 ET | 300 | 3.68 |
| 02:51 ET | 1330 | 3.66 |
| 02:54 ET | 721 | 3.69 |
| 02:56 ET | 590 | 3.685 |
| 02:58 ET | 100 | 3.685 |
| 03:00 ET | 2801 | 3.7 |
| 03:02 ET | 2191 | 3.705 |
| 03:05 ET | 743 | 3.7 |
| 03:09 ET | 500 | 3.72 |
| 03:12 ET | 100 | 3.715 |
| 03:16 ET | 2443 | 3.73 |
| 03:18 ET | 15592 | 3.7322 |
| 03:20 ET | 674 | 3.7102 |
| 03:21 ET | 100 | 3.722 |
| 03:25 ET | 480 | 3.7122 |
| 03:30 ET | 384 | 3.7275 |
| 03:32 ET | 1221 | 3.73 |
| 03:34 ET | 4429 | 3.7688 |
| 03:36 ET | 1300 | 3.78 |
| 03:38 ET | 600 | 3.7739 |
| 03:39 ET | 1550 | 3.77 |
| 03:41 ET | 200 | 3.78 |
| 03:43 ET | 100 | 3.76 |
| 03:50 ET | 200 | 3.75 |
| 03:56 ET | 750 | 3.72 |
| 03:57 ET | 5701 | 3.6651 |
| 03:59 ET | 3038 | 3.63 |
Yesterday
DJ T2 Biosystems Shares Soar on Narrower 1Q Loss, Plus Debt-to-Equity and Distribution Pacts, from 14 hours ago by Dow Jones
14 hours ago by Dow JonesT2 Biosystems Announces First Quarter 2024 Financial Results, from 16 hours ago by Dow Jones
16 hours ago by Dow Jones*DJ T2 Biosystems 1Q Loss/Shr $2.66 >TTOO, from 16 hours ago by Dow Jones
16 hours ago by Dow JonesT2 Biosystems Announces Commercial Expansion Through Middle East Distributor, from 16 hours ago by Dow Jones
16 hours ago by Dow JonesT2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity, from 16 hours ago by Dow Jones
16 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
T2 Biosystems Inc | 31.9M | 0.0x | --- |
Co-Diagnostics Inc | 39.4M | -1.0x | --- |
Neuroone Medical Technologies Corp | 30.3M | -1.7x | --- |
Avinger Inc | 6.5M | -0.1x | --- |
EUDA Health Holdings Ltd | 46.8M | -1.4x | --- |
Akili Inc | 33.2M | -0.6x | --- |
Company Information
T2 Biosystems, Inc. is an in vitro diagnostics company focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. Its technology enables detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its focus includes three areas: sepsis, bioterrorism, and Lyme disease. The Company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the T2 Magnetic Resonance (T2MR) technology. It also has an active pipeline of products, including the United States T2Resistance Panel, the Candida auris test, and the T2Lyme Panel. T2Dx Instrument is a fully automated instrument that is capable of running a range of diagnostic tests from patient samples.
Contact Information
- Headquarters
- 101 Hartwell AveLEXINGTON, MA, United States 02421-3125
- Phone
- 781-457-1200
- Fax
- 781-357-3080
Executives
- Chairman of the Board, President, Chief Executive Officer
- John Sperzel
- Chief Financial Officer
- John Sprague
- Senior Vice President, General Counsel
- Michael Gibbs
- Senior Vice President of Science Research and Development
- Roger Smith
- Chief Commercial Officer
- Brett Giffin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $31.9M |
|---|---|
Revenue (TTM) | $7.2M |
Shares Outstanding | 8.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.03 |
EPS | $-147.02 |
Book Value | $-6.91 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 4.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -690.45% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
